In order to categorize a Tablet as a drug of high quality, it must adhere to specific standards. The primary factors used to evaluate the quality of any tablet product include its safety, potency, effectiveness, stability, patient acceptance, and adherence to regulatory guidelines. The assessment of tablet quality must be undertaken during the development phase of the product. During the product’s design and assembly, it is imperative to establish the physical, chemical, and biological parameters necessary to ensure compliance with quality requirements and the setting of quality objectives. The utilization of in-process quality control (IPQC) testing is crucial during production to guarantee the quality of the final product. These tests, conducted throughout the manufacturing process, enable the monitoring and adjustment of operations to ensure that the product aligns with specifications, ultimately resulting in tablets of excellent quality. The main aim of IPQC is to prevent or rectify errors at each stage of production, thus yielding an impeccable finished product. Once the manufacturing process concludes, finished product quality control (FPQC) tests, in accordance with the specifications outlined in the pharmacopoeia, are performed on the pharmaceutical tablets. Such tests are instrumental in assessing whether the quality parameters fall within acceptable limits. The purpose of this study is to provide IPQC and FPQC testing for pharmaceutical tablets in accordance with the pharmacopoeia guidelines.